10
total announcements
524572.BO · 15 min delayed
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has closed its trading window for 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026, as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has filed two complaints against M/s Anugraha Chemicals and its partners for dishonour of two cheques worth ₹2,62,50,000, payable to the Company. The Company is seeking recovery of the outstanding amount.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has announced the voting results of its 37th Annual General Meeting (AGM) held on September 11, 2026, through video conferencing. The company has passed four resolutions, including the adoption of audited financial statements and the appointment of an executive director. The resolutions were passed with high voting percentages, with the promoter group voting in favor of all resolutions.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has published a newspaper advertisement regarding the Notice of 37th Annual General Meeting of the Company, scheduled on September 11, 2026, through Video Conferencing/Other Audio Visual Means.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has released its 37th Annual Report for the financial year 2025-26, which includes the notice of the 37th Annual General Meeting and the company's financial and non-financial performance during the year.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has announced the notice of its 37th Annual General Meeting (AGM) and Annual Report for the financial year 2025-2026. The AGM will be held on September 11, 2026, and the Annual Report is available on the company's website and through email to registered members.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd published unaudited financial results for the quarter ended June 30, 2026, in accordance with Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, and has announced the date of its 37th Annual General Meeting.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved the notice of its 37th Annual General Meeting to be held through video conferencing.
Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the Unaudited Financial Results (standalone and consolidated) for the quarter ended 30th June 2026.